| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 06/12/2003 | US20030109541 3-Phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmia |
| 06/11/2003 | EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 06/05/2003 | WO2002085843A3 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 06/05/2003 | US20030105123 For therapy of respiratory system disorders |
| 06/05/2003 | US20030105102 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity |
| 06/04/2003 | EP0819120B1 Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 06/04/2003 | CN1422253A Carbamate caspase inhibitors and uses thereof |
| 06/04/2003 | CN1110497C Di-or triaza-spiral [4,5] decane derivative |
| 06/03/2003 | US6573379 Method for preparing halomethyl heterocyclic compounds |
| 06/03/2003 | CA2116224C Novel alpha-mannosidase inhibitors |
| 05/30/2003 | WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease |
| 05/30/2003 | WO2003043582A2 Modulators of rho c activity |
| 05/30/2003 | CA2467476A1 Amino diols useful in the treatment of alzheimer's disease |
| 05/29/2003 | US20030099807 Optical recording medium |
| 05/28/2003 | EP1314727A1 Direct synthesis of quaternary phenanthridinium salts |
| 05/28/2003 | EP1313725A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 05/28/2003 | EP0850222B1 Piperazine derivatives and process for the preparation thereof |
| 05/28/2003 | EP0690715B1 Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| 05/28/2003 | CN1109672C Process for prodn. of (Z)-1-[1-(4-methoxybenzylidene)-1,2,3,4,5,6,7,8-octahydro-isoquinolin-2-yl] alkanones |
| 05/27/2003 | CA2213054C Novel bis(imido) derivatives, a process for their preparation and pharmaceutical compositions containing them |
| 05/22/2003 | WO2003042135A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
| 05/22/2003 | US20030096833 Use in inhibiting inflammation, cell death and in treating shock and reperfusion injuries |
| 05/22/2003 | US20030096192 For application to polycarbonate substrate by spin coating or vapor deposition |
| 05/22/2003 | CA2466449A1 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
| 05/21/2003 | EP1311486A1 Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same |
| 05/21/2003 | EP0874827B1 Quinoline derivatives as nk3 antagonists |
| 05/20/2003 | US6566547 Fungicides |
| 05/20/2003 | US6566368 Aministering apomorphine or a pharmaceutically acceptable acid addition salt thereof intranasally and in an amount sufficient to induce an erection adequate for vaginal penetration but less than the amount that induces substantial nausea |
| 05/20/2003 | US6566071 Useful as fluorescent labeling reagents |
| 05/15/2003 | WO2003040140A1 Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine) |
| 05/15/2003 | US20030092712 Antiinflammatory agents; rheumatic diseases |
| 05/15/2003 | US20030092704 Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 05/14/2003 | EP1309553A1 New aporphine esters and their use in therapy |
| 05/14/2003 | CN1418110A Remedies for sjoegrens syndrome |
| 05/14/2003 | CN1418099A Choice compound for treatment of fibromyalgia and chronic fatigue syndrome |
| 05/14/2003 | CN1108301C Inhibitors of microsomal triglyceride transfer protein and mothed |
| 05/13/2003 | US6562976 Such as methyl-2-cyclopentyl-4-(4-fluorophenyl)-5-oxo-7,7-dimethyl-1,4,5,6,7,8 -hexahydroquinoline-3-carboxylate for treatment of arteriosclerosis and dyslipidaemias; condensation |
| 05/13/2003 | US6562972 Method for preparing quinoxaline-5- and 6-carboxylic acids (I) which comprises contacting an aqueous alkaline suspension of a 5- or 6-halomethyl quinoxaline (II) with oxygen in the presence of a transition metal catalyst, to form the |
| 05/08/2003 | WO2003037329A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome |
| 05/08/2003 | US20030087948 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 05/08/2003 | US20030087926 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 05/08/2003 | US20030087306 Methods for identifying novel multimeric agents that modulate receptors |
| 05/08/2003 | CA2460118A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome |
| 05/07/2003 | EP0981527B1 Salt of naphthyridine carboxylic acid derivative |
| 05/07/2003 | EP0806416B1 Huperzine a derivatives, their preparation and their use |
| 05/07/2003 | CN1107677C Camptothecin derivatives and use thereof as antimutor agents |
| 05/07/2003 | CN1107502C Prepn. method for medicinal compsn. contg. hydrogonated pyridine derivative as active components |
| 05/06/2003 | US6559308 The present invention relates to a method for preparing quinoxaline-5- and 6-carboxylic acids. The method comprises contacting an aqueous suspension of a 5- or 6-hydroxymethyl quinoxaline with oxygen in the presence of a transition metal |
| 05/06/2003 | US6559162 Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 05/06/2003 | US6559159 Kappa opioid receptor ligands |
| 05/02/2003 | EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 05/01/2003 | WO2003035069A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
| 05/01/2003 | CA2464261A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
| 04/30/2003 | CN1414853A Oral mucosal dosage forms of apomorphine |
| 04/30/2003 | CN1413988A Substituted transannular tetracarboxylic acid diimide |
| 04/29/2003 | US6555550 Musarinic agonists and antagonists |
| 04/24/2003 | WO2002060436A8 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states |
| 04/24/2003 | WO2002056875A3 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 04/24/2003 | US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 04/24/2003 | US20030078254 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 04/23/2003 | EP0873315B1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 04/23/2003 | CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 04/22/2003 | US6552032 Opiate compounds, methods of making and methods of use |
| 04/22/2003 | US6552017 Substituted heterocycle fused gamma-carbolines |
| 04/22/2003 | CA2308780C Novel derivatives of 2,3-methanoamino acids, process for their preparation and pharmaceutical compositions containing them |
| 04/22/2003 | CA2287054C 1,3,8-triazaspiro¬4,5|decanone compounds as orl1-receptor agonists |
| 04/17/2003 | WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/17/2003 | US20030073841 New benzo [b] pyrano [3,2-h] acridin-7-one compounds |
| 04/17/2003 | US20030073716 Therapy for drug abruse; side effect reduction |
| 04/17/2003 | US20030073715 Nasal administering; side effect reduction |
| 04/17/2003 | US20030071268 Optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer |
| 04/17/2003 | CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/15/2003 | US6548515 Use as anticancer agents |
| 04/15/2003 | US6548493 Substituted heterocycle fused gamma-carbolines |
| 04/15/2003 | CA2169737C Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives |
| 04/10/2003 | WO2003028727A1 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors |
| 04/10/2003 | US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/10/2003 | CA2462030A1 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors |
| 04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
| 04/08/2003 | US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane |
| 04/08/2003 | US6545011 PARP (poly(adenosine 5'-diphospho-ribose) polymerase) inhibitors |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065006 Viricides; anticancer agents |
| 04/03/2003 | US20030065004 Androgen receptor modulators and methods for use thereof |
| 04/03/2003 | US20030064968 Viricides, anticarcinogneic agents |
| 04/03/2003 | US20030064315 N,N'-ditrifluoromethanesulphonyloxy-4,4'-(phenylene-1,3-dioxy) dinaphthalene-1,8:1',8'-tetracarboxylic imide increases the degree of polymerization; for passivation layer, buffer coating, or dielectric film in printed circuits |
| 04/02/2003 | EP1297835A1 Benzo[b]pyrano[3,2-h]acridin-7-one derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 04/02/2003 | EP1296955A1 Process for the manufacture of 1,8-naphthalimide |
| 04/02/2003 | EP0912512B1 Sulphonamide derivatives and their use in the treatment of cns disorders |
| 04/02/2003 | EP0873295B1 Dimer-selective rxr modulators and methods for their use |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541470 Have a potent antiviral activity against picornaviruses and rotaviruses. |
| 03/27/2003 | WO2002098854A3 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 03/27/2003 | WO2002060879A3 Bacterial gyrase inhibitors and uses thereof |
| 03/27/2003 | US20030060624 Reacting 2-chloro-4- trifluoromethyl-phenyl)-acetonitrile in the presence of a palladium catalyst and a base to form indene derivative |
| 03/26/2003 | EP1294696A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 03/26/2003 | EP1294695A2 Substituted diamide derivatives useful as motilin antagonists |
| 03/26/2003 | CN1406227A Aryl fused azapolycy clic compounds |
| 03/25/2003 | US6538005 As inhibitors of phosphodiesterases; therapy |
| 03/25/2003 | US6538003 Pyridopyranoazepine derivatives, their preparation and their therapeutic application |